Home > > > > > Report Detail

Global Drugs for Malaria Market Insights, Forecast to 2026

Publisher Name :
Date: 30-Apr-2020
No. of pages: 117
Inquire Before Buying

Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.

Anti-malarial Drugs are available only with a physician's prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.

The classification of drugs for malaria includes aryl aminoalcohol compounds, antifolate compounds and artemisinin compounds. The proportion of aryl aminoalcohol compounds drugs for malaria in 2016 is about 16.8%, the proportion of antifolate compounds in 2016 is about 55.4% and the proportion of artemisinin compounds in 2016 is about 27.8%.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Drugs for Malaria 3900 market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Drugs for Malaria 3900 industry.

Based on our recent survey, we have several different scenarios about the Drugs for Malaria 3900 YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Drugs for Malaria 3900 will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Drugs for Malaria market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Drugs for Malaria market in terms of both revenue and volume.

Players, stakeholders, and other participants in the global Drugs for Malaria market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.

Sales and Pricing Analyses

Readers are provided with deeper sales analysis and pricing analysis for the global Drugs for Malaria market. As part of sales analysis, the report offers accurate statistics and figures for sales and revenue by region, by each type segment for the period 2015-2026.

In the pricing analysis section of the report, readers are provided with validated statistics and figures for the price by players and price by region for the period 2015-2020 and price by each type segment for the period 2015-2020.

Regional and Country-level Analysis

The report offers an exhaustive geographical analysis of the global Drugs for Malaria market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of sales for the period 2015-2026.

Competition Analysis

In the competitive analysis section of the report, leading as well as prominent players of the global Drugs for Malaria market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Drugs for Malaria market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Drugs for Malaria market.

The following manufacturers are covered in this report:

- Cipla

- Guilin Pharmaceutical

- IPCA Laboratories

- GlaxoSmithKline

- Mylan Labs

- Roche

- Novartis

- Sanofi Aventis

- Ajanta Pharma

Drugs for Malaria Breakdown Data by Type

- Aryl Aminoalcohol Compounds

- Antifolate Compounds

- Artemisinin Compounds

Drugs for Malaria Breakdown Data by Application

- Prevention

- Treatment

- Other

Global Drugs for Malaria Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Drugs for Malaria Product Introduction
1.2 Market Segments
1.3 Key Drugs for Malaria Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Drugs for Malaria Market Size Growth Rate by Type
1.4.2 Aryl Aminoalcohol Compounds
1.4.3 Antifolate Compounds
1.4.4 Artemisinin Compounds
1.5 Market by Application
1.5.1 Global Drugs for Malaria Market Size Growth Rate by Application
1.5.2 Prevention
1.5.3 Treatment
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Drugs for Malaria Industry Impact
1.6.1 How the Covid-19 is Affecting the Drugs for Malaria Industry
1.6.1.1 Drugs for Malaria Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Drugs for Malaria Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Drugs for Malaria Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Drugs for Malaria Market Size Estimates and Forecasts
2.1.1 Global Drugs for Malaria Revenue 2015-2026
2.1.2 Global Drugs for Malaria Sales 2015-2026
2.2 Drugs for Malaria Market Size by Region: 2020 Versus 2026
2.2.1 Global Drugs for Malaria Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Drugs for Malaria Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Drugs for Malaria Competitor Landscape by Players
3.1 Drugs for Malaria Sales by Manufacturers
3.1.1 Drugs for Malaria Sales by Manufacturers (2015-2020)
3.1.2 Drugs for Malaria Sales Market Share by Manufacturers (2015-2020)
3.2 Drugs for Malaria Revenue by Manufacturers
3.2.1 Drugs for Malaria Revenue by Manufacturers (2015-2020)
3.2.2 Drugs for Malaria Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Drugs for Malaria Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Drugs for Malaria Revenue in 2019
3.2.5 Global Drugs for Malaria Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Drugs for Malaria Price by Manufacturers
3.4 Drugs for Malaria Manufacturing Base Distribution, Product Types
3.4.1 Drugs for Malaria Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Drugs for Malaria Product Type
3.4.3 Date of International Manufacturers Enter into Drugs for Malaria Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Drugs for Malaria Market Size by Type (2015-2020)
4.1.1 Global Drugs for Malaria Sales by Type (2015-2020)
4.1.2 Global Drugs for Malaria Revenue by Type (2015-2020)
4.1.3 Drugs for Malaria Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Drugs for Malaria Market Size Forecast by Type (2021-2026)
4.2.1 Global Drugs for Malaria Sales Forecast by Type (2021-2026)
4.2.2 Global Drugs for Malaria Revenue Forecast by Type (2021-2026)
4.2.3 Drugs for Malaria Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Drugs for Malaria Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Drugs for Malaria Market Size by Application (2015-2020)
5.1.1 Global Drugs for Malaria Sales by Application (2015-2020)
5.1.2 Global Drugs for Malaria Revenue by Application (2015-2020)
5.1.3 Drugs for Malaria Price by Application (2015-2020)
5.2 Drugs for Malaria Market Size Forecast by Application (2021-2026)
5.2.1 Global Drugs for Malaria Sales Forecast by Application (2021-2026)
5.2.2 Global Drugs for Malaria Revenue Forecast by Application (2021-2026)
5.2.3 Global Drugs for Malaria Price Forecast by Application (2021-2026)
6 North America
6.1 North America Drugs for Malaria by Country
6.1.1 North America Drugs for Malaria Sales by Country
6.1.2 North America Drugs for Malaria Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Drugs for Malaria Market Facts & Figures by Type
6.3 North America Drugs for Malaria Market Facts & Figures by Application
7 Europe
7.1 Europe Drugs for Malaria by Country
7.1.1 Europe Drugs for Malaria Sales by Country
7.1.2 Europe Drugs for Malaria Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Drugs for Malaria Market Facts & Figures by Type
7.3 Europe Drugs for Malaria Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Drugs for Malaria by Region
8.1.1 Asia Pacific Drugs for Malaria Sales by Region
8.1.2 Asia Pacific Drugs for Malaria Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Drugs for Malaria Market Facts & Figures by Type
8.3 Asia Pacific Drugs for Malaria Market Facts & Figures by Application
9 Latin America
9.1 Latin America Drugs for Malaria by Country
9.1.1 Latin America Drugs for Malaria Sales by Country
9.1.2 Latin America Drugs for Malaria Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Drugs for Malaria Market Facts & Figures by Type
9.3 Central & South America Drugs for Malaria Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Drugs for Malaria by Country
10.1.1 Middle East and Africa Drugs for Malaria Sales by Country
10.1.2 Middle East and Africa Drugs for Malaria Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Drugs for Malaria Market Facts & Figures by Type
10.3 Middle East and Africa Drugs for Malaria Market Facts & Figures by Application
11 Company Profiles
11.1 Cipla
11.1.1 Cipla Corporation Information
11.1.2 Cipla Description, Business Overview and Total Revenue
11.1.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Cipla Drugs for Malaria Products Offered
11.1.5 Cipla Recent Development
11.2 Guilin Pharmaceutical
11.2.1 Guilin Pharmaceutical Corporation Information
11.2.2 Guilin Pharmaceutical Description, Business Overview and Total Revenue
11.2.3 Guilin Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Guilin Pharmaceutical Drugs for Malaria Products Offered
11.2.5 Guilin Pharmaceutical Recent Development
11.3 IPCA Laboratories
11.3.1 IPCA Laboratories Corporation Information
11.3.2 IPCA Laboratories Description, Business Overview and Total Revenue
11.3.3 IPCA Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.3.4 IPCA Laboratories Drugs for Malaria Products Offered
11.3.5 IPCA Laboratories Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Corporation Information
11.4.2 GlaxoSmithKline Description, Business Overview and Total Revenue
11.4.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.4.4 GlaxoSmithKline Drugs for Malaria Products Offered
11.4.5 GlaxoSmithKline Recent Development
11.5 Mylan Labs
11.5.1 Mylan Labs Corporation Information
11.5.2 Mylan Labs Description, Business Overview and Total Revenue
11.5.3 Mylan Labs Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Mylan Labs Drugs for Malaria Products Offered
11.5.5 Mylan Labs Recent Development
11.6 Roche
11.6.1 Roche Corporation Information
11.6.2 Roche Description, Business Overview and Total Revenue
11.6.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Roche Drugs for Malaria Products Offered
11.6.5 Roche Recent Development
11.7 Novartis
11.7.1 Novartis Corporation Information
11.7.2 Novartis Description, Business Overview and Total Revenue
11.7.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Novartis Drugs for Malaria Products Offered
11.7.5 Novartis Recent Development
11.8 Sanofi Aventis
11.8.1 Sanofi Aventis Corporation Information
11.8.2 Sanofi Aventis Description, Business Overview and Total Revenue
11.8.3 Sanofi Aventis Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Sanofi Aventis Drugs for Malaria Products Offered
11.8.5 Sanofi Aventis Recent Development
11.9 Ajanta Pharma
11.9.1 Ajanta Pharma Corporation Information
11.9.2 Ajanta Pharma Description, Business Overview and Total Revenue
11.9.3 Ajanta Pharma Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Ajanta Pharma Drugs for Malaria Products Offered
11.9.5 Ajanta Pharma Recent Development
11.1 Cipla
11.1.1 Cipla Corporation Information
11.1.2 Cipla Description, Business Overview and Total Revenue
11.1.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Cipla Drugs for Malaria Products Offered
11.1.5 Cipla Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Drugs for Malaria Market Estimates and Projections by Region
12.1.1 Global Drugs for Malaria Sales Forecast by Regions 2021-2026
12.1.2 Global Drugs for Malaria Revenue Forecast by Regions 2021-2026
12.2 North America Drugs for Malaria Market Size Forecast (2021-2026)
12.2.1 North America: Drugs for Malaria Sales Forecast (2021-2026)
12.2.2 North America: Drugs for Malaria Revenue Forecast (2021-2026)
12.2.3 North America: Drugs for Malaria Market Size Forecast by Country (2021-2026)
12.3 Europe Drugs for Malaria Market Size Forecast (2021-2026)
12.3.1 Europe: Drugs for Malaria Sales Forecast (2021-2026)
12.3.2 Europe: Drugs for Malaria Revenue Forecast (2021-2026)
12.3.3 Europe: Drugs for Malaria Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Drugs for Malaria Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Drugs for Malaria Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Drugs for Malaria Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Drugs for Malaria Market Size Forecast by Region (2021-2026)
12.5 Latin America Drugs for Malaria Market Size Forecast (2021-2026)
12.5.1 Latin America: Drugs for Malaria Sales Forecast (2021-2026)
12.5.2 Latin America: Drugs for Malaria Revenue Forecast (2021-2026)
12.5.3 Latin America: Drugs for Malaria Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Drugs for Malaria Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Drugs for Malaria Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Drugs for Malaria Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Drugs for Malaria Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Drugs for Malaria Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Drugs for Malaria Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
Table 1. Drugs for Malaria Market Segments
Table 2. Ranking of Global Top Drugs for Malaria Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Drugs for Malaria Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Aryl Aminoalcohol Compounds
Table 5. Major Manufacturers of Antifolate Compounds
Table 6. Major Manufacturers of Artemisinin Compounds
Table 7. COVID-19 Impact Global Market: (Four Drugs for Malaria Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Drugs for Malaria Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Drugs for Malaria Players to Combat Covid-19 Impact
Table 12. Global Drugs for Malaria Market Size Growth Rate by Application 2020-2026 (K Units)
Table 13. Global Drugs for Malaria Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 14. Global Drugs for Malaria Sales by Regions 2015-2020 (K Units)
Table 15. Global Drugs for Malaria Sales Market Share by Regions (2015-2020)
Table 16. Global Drugs for Malaria Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Drugs for Malaria Sales by Manufacturers (2015-2020) (K Units)
Table 18. Global Drugs for Malaria Sales Share by Manufacturers (2015-2020)
Table 19. Global Drugs for Malaria Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Drugs for Malaria by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for Malaria as of 2019)
Table 21. Drugs for Malaria Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Drugs for Malaria Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Drugs for Malaria Price (2015-2020) (USD/Unit)
Table 24. Drugs for Malaria Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Drugs for Malaria Product Type
Table 26. Date of International Manufacturers Enter into Drugs for Malaria Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Drugs for Malaria Sales by Type (2015-2020) (K Units)
Table 29. Global Drugs for Malaria Sales Share by Type (2015-2020)
Table 30. Global Drugs for Malaria Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Drugs for Malaria Revenue Share by Type (2015-2020)
Table 32. Drugs for Malaria Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 33. Global Drugs for Malaria Sales by Application (2015-2020) (K Units)
Table 34. Global Drugs for Malaria Sales Share by Application (2015-2020)
Table 35. North America Drugs for Malaria Sales by Country (2015-2020) (K Units)
Table 36. North America Drugs for Malaria Sales Market Share by Country (2015-2020)
Table 37. North America Drugs for Malaria Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Drugs for Malaria Revenue Market Share by Country (2015-2020)
Table 39. North America Drugs for Malaria Sales by Type (2015-2020) (K Units)
Table 40. North America Drugs for Malaria Sales Market Share by Type (2015-2020)
Table 41. North America Drugs for Malaria Sales by Application (2015-2020) (K Units)
Table 42. North America Drugs for Malaria Sales Market Share by Application (2015-2020)
Table 43. Europe Drugs for Malaria Sales by Country (2015-2020) (K Units)
Table 44. Europe Drugs for Malaria Sales Market Share by Country (2015-2020)
Table 45. Europe Drugs for Malaria Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Drugs for Malaria Revenue Market Share by Country (2015-2020)
Table 47. Europe Drugs for Malaria Sales by Type (2015-2020) (K Units)
Table 48. Europe Drugs for Malaria Sales Market Share by Type (2015-2020)
Table 49. Europe Drugs for Malaria Sales by Application (2015-2020) (K Units)
Table 50. Europe Drugs for Malaria Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Drugs for Malaria Sales by Region (2015-2020) (K Units)
Table 52. Asia Pacific Drugs for Malaria Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Drugs for Malaria Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Drugs for Malaria Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Drugs for Malaria Sales by Type (2015-2020) (K Units)
Table 56. Asia Pacific Drugs for Malaria Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Drugs for Malaria Sales by Application (2015-2020) (K Units)
Table 58. Asia Pacific Drugs for Malaria Sales Market Share by Application (2015-2020)
Table 59. Latin America Drugs for Malaria Sales by Country (2015-2020) (K Units)
Table 60. Latin America Drugs for Malaria Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Drugs for Malaria Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Drugs for Malaria Revenue Market Share by Country (2015-2020)
Table 63. Latin America Drugs for Malaria Sales by Type (2015-2020) (K Units)
Table 64. Latin America Drugs for Malaria Sales Market Share by Type (2015-2020)
Table 65. Latin America Drugs for Malaria Sales by Application (2015-2020) (K Units)
Table 66. Latin America Drugs for Malaria Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Drugs for Malaria Sales by Country (2015-2020) (K Units)
Table 68. Middle East and Africa Drugs for Malaria Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Drugs for Malaria Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Drugs for Malaria Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Drugs for Malaria Sales by Type (2015-2020) (K Units)
Table 72. Middle East and Africa Drugs for Malaria Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Drugs for Malaria Sales by Application (2015-2020) (K Units)
Table 74. Middle East and Africa Drugs for Malaria Sales Market Share by Application (2015-2020)
Table 75. Cipla Corporation Information
Table 76. Cipla Description and Major Businesses
Table 77. Cipla Drugs for Malaria Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Cipla Product
Table 79. Cipla Recent Development
Table 80. Guilin Pharmaceutical Corporation Information
Table 81. Guilin Pharmaceutical Description and Major Businesses
Table 82. Guilin Pharmaceutical Drugs for Malaria Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Guilin Pharmaceutical Product
Table 84. Guilin Pharmaceutical Recent Development
Table 85. IPCA Laboratories Corporation Information
Table 86. IPCA Laboratories Description and Major Businesses
Table 87. IPCA Laboratories Drugs for Malaria Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. IPCA Laboratories Product
Table 89. IPCA Laboratories Recent Development
Table 90. GlaxoSmithKline Corporation Information
Table 91. GlaxoSmithKline Description and Major Businesses
Table 92. GlaxoSmithKline Drugs for Malaria Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. GlaxoSmithKline Product
Table 94. GlaxoSmithKline Recent Development
Table 95. Mylan Labs Corporation Information
Table 96. Mylan Labs Description and Major Businesses
Table 97. Mylan Labs Drugs for Malaria Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Mylan Labs Product
Table 99. Mylan Labs Recent Development
Table 100. Roche Corporation Information
Table 101. Roche Description and Major Businesses
Table 102. Roche Drugs for Malaria Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Roche Product
Table 104. Roche Recent Development
Table 105. Novartis Corporation Information
Table 106. Novartis Description and Major Businesses
Table 107. Novartis Drugs for Malaria Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Novartis Product
Table 109. Novartis Recent Development
Table 110. Sanofi Aventis Corporation Information
Table 111. Sanofi Aventis Description and Major Businesses
Table 112. Sanofi Aventis Drugs for Malaria Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Sanofi Aventis Product
Table 114. Sanofi Aventis Recent Development
Table 115. Ajanta Pharma Corporation Information
Table 116. Ajanta Pharma Description and Major Businesses
Table 117. Ajanta Pharma Drugs for Malaria Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Ajanta Pharma Product
Table 119. Ajanta Pharma Recent Development
Table 120. Global Drugs for Malaria Sales Forecast by Regions (2021-2026) (K Units)
Table 121. Global Drugs for Malaria Sales Market Share Forecast by Regions (2021-2026)
Table 122. Global Drugs for Malaria Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 123. Global Drugs for Malaria Revenue Market Share Forecast by Regions (2021-2026)
Table 124. North America: Drugs for Malaria Sales Forecast by Country (2021-2026) (K Units)
Table 125. North America: Drugs for Malaria Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Europe: Drugs for Malaria Sales Forecast by Country (2021-2026) (K Units)
Table 127. Europe: Drugs for Malaria Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Asia Pacific: Drugs for Malaria Sales Forecast by Region (2021-2026) (K Units)
Table 129. Asia Pacific: Drugs for Malaria Revenue Forecast by Region (2021-2026) (US$ Million)
Table 130. Latin America: Drugs for Malaria Sales Forecast by Country (2021-2026) (K Units)
Table 131. Latin America: Drugs for Malaria Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Middle East and Africa: Drugs for Malaria Sales Forecast by Country (2021-2026) (K Units)
Table 133. Middle East and Africa: Drugs for Malaria Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 135. Key Challenges
Table 136. Market Risks
Table 137. Main Points Interviewed from Key Drugs for Malaria Players
Table 138. Drugs for Malaria Customers List
Table 139. Drugs for Malaria Distributors List
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Drugs for Malaria Product Picture
Figure 2. Global Drugs for Malaria Sales Market Share by Type in 2020 & 2026
Figure 3. Aryl Aminoalcohol Compounds Product Picture
Figure 4. Antifolate Compounds Product Picture
Figure 5. Artemisinin Compounds Product Picture
Figure 6. Global Drugs for Malaria Sales Market Share by Application in 2020 & 2026
Figure 7. Prevention
Figure 8. Treatment
Figure 9. Other
Figure 10. Drugs for Malaria Report Years Considered
Figure 11. Global Drugs for Malaria Market Size 2015-2026 (US$ Million)
Figure 12. Global Drugs for Malaria Sales 2015-2026 (K Units)
Figure 13. Global Drugs for Malaria Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Drugs for Malaria Sales Market Share by Region (2015-2020)
Figure 15. Global Drugs for Malaria Sales Market Share by Region in 2019
Figure 16. Global Drugs for Malaria Revenue Market Share by Region (2015-2020)
Figure 17. Global Drugs for Malaria Revenue Market Share by Region in 2019
Figure 18. Global Drugs for Malaria Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Drugs for Malaria Revenue in 2019
Figure 20. Drugs for Malaria Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Drugs for Malaria Sales Market Share by Type (2015-2020)
Figure 22. Global Drugs for Malaria Sales Market Share by Type in 2019
Figure 23. Global Drugs for Malaria Revenue Market Share by Type (2015-2020)
Figure 24. Global Drugs for Malaria Revenue Market Share by Type in 2019
Figure 25. Global Drugs for Malaria Market Share by Price Range (2015-2020)
Figure 26. Global Drugs for Malaria Sales Market Share by Application (2015-2020)
Figure 27. Global Drugs for Malaria Sales Market Share by Application in 2019
Figure 28. Global Drugs for Malaria Revenue Market Share by Application (2015-2020)
Figure 29. Global Drugs for Malaria Revenue Market Share by Application in 2019
Figure 30. North America Drugs for Malaria Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Drugs for Malaria Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Drugs for Malaria Sales Market Share by Country in 2019
Figure 33. North America Drugs for Malaria Revenue Market Share by Country in 2019
Figure 34. U.S. Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Drugs for Malaria Market Share by Type in 2019
Figure 39. North America Drugs for Malaria Market Share by Application in 2019
Figure 40. Europe Drugs for Malaria Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Drugs for Malaria Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Drugs for Malaria Sales Market Share by Country in 2019
Figure 43. Europe Drugs for Malaria Revenue Market Share by Country in 2019
Figure 44. Germany Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Drugs for Malaria Market Share by Type in 2019
Figure 55. Europe Drugs for Malaria Market Share by Application in 2019
Figure 56. Asia Pacific Drugs for Malaria Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Drugs for Malaria Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Drugs for Malaria Sales Market Share by Region in 2019
Figure 59. Asia Pacific Drugs for Malaria Revenue Market Share by Region in 2019
Figure 60. China Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Drugs for Malaria Market Share by Type in 2019
Figure 83. Asia Pacific Drugs for Malaria Market Share by Application in 2019
Figure 84. Latin America Drugs for Malaria Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Drugs for Malaria Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Drugs for Malaria Sales Market Share by Country in 2019
Figure 87. Latin America Drugs for Malaria Revenue Market Share by Country in 2019
Figure 88. Mexico Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Drugs for Malaria Market Share by Type in 2019
Figure 95. Latin America Drugs for Malaria Market Share by Application in 2019
Figure 96. Middle East and Africa Drugs for Malaria Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Drugs for Malaria Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Drugs for Malaria Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Drugs for Malaria Revenue Market Share by Country in 2019
Figure 100. Turkey Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. UAE Drugs for Malaria Sales Growth Rate (2015-2020) (K Units)
Figure 105. UAE Drugs for Malaria Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Drugs for Malaria Market Share by Type in 2019
Figure 107. Middle East and Africa Drugs for Malaria Market Share by Application in 2019
Figure 108. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Guilin Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. IPCA Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Mylan Labs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Sanofi Aventis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Ajanta Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. North America Drugs for Malaria Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. North America Drugs for Malaria Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Europe Drugs for Malaria Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 120. Europe Drugs for Malaria Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Asia Pacific Drugs for Malaria Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 122. Asia Pacific Drugs for Malaria Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Latin America Drugs for Malaria Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 124. Latin America Drugs for Malaria Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Middle East and Africa Drugs for Malaria Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 126. Middle East and Africa Drugs for Malaria Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Porter's Five Forces Analysis
Figure 128. Channels of Distribution
Figure 129. Distributors Profiles
Figure 130. Bottom-up and Top-down Approaches for This Report
Figure 131. Data Triangulation
Figure 132. Key Executives Interviewed
  • Global Dihydroartemisinin Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 88
    The global Dihydroartemisinin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Dihydroartemisinin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Dihydroartemisinin is estimated to increase from $ million in 2023 to reach $ million by 2......
  • Global Artemisinin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114
    According to our LPI (LP Information) latest study, the global Artemisinin market size was valued at US$ 61 million in 2023. With growing demand in downstream market, the Artemisinin is forecast to a readjusted size of US$ 227 million by 2030 with a CAGR of 20.7% during review period. The research report highlights the growth potential of the global Artemisinin market. Artemisinin are expected to show stable growth in the future market. However, product differentiation, reducing costs, a......
  • Global Drugs for Malaria Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Drugs for Malaria market size was valued at US$ million in 2023. With growing demand in downstream market, the Drugs for Malaria is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Drugs for Malaria market. Drugs for Malaria are expected to show stable growth in the future market. However, product differentiation, reduc......
  • Dihydroartemisinin - Global Market Insights and Sales Trends 2024
    Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 99
    The global Dihydroartemisinin market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Dihydroartemisinin in various end use industries. The expanding demands from the Malaria Treatment, Scientific Research and Others,, are propelling Dihydroartemisinin market. Pharmaceutical Grade, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......
  • Global Drugs For Malaria Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 100
    Market Overview of Global Drugs For Malaria market: According to our latest research, the global Drugs For Malaria market looks promising in the next 5 years. As of 2022, the global Drugs For Malaria market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. It is Anti-malarial drug. Anti-malarial drugs are the medicines used to prevent and treat malaria. The malaria is the disease caused due to ......
  • Global Artemisinin Professional Survey Report 2023, Forecast to 2028
    Published: 15-Nov-2023        Price: US 3280 Onwards        Pages: 105
    Artemisinin and its semisynthetic derivatives are a group of drugs used in the treatment of malaria due to Plasmodium falciparum. It was discovered in 1972 by Tu Youyou, who shared the 2015 Nobel Prize in Physiology or Medicine for her discovery. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clie......
  • Global Artemisinin Market Research Report 2023, Forecast to 2028
    Published: 15-Nov-2023        Price: US 2680 Onwards        Pages: 131
    Artemisinin and its semisynthetic derivatives are a group of drugs used in the treatment of malaria due to Plasmodium falciparum. It was discovered in 1972 by Tu Youyou, who shared the 2015 Nobel Prize in Physiology or Medicine for her discovery. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clie......
  • Global Dihydroartemisinin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 24-Oct-2023        Price: US 3380 Onwards        Pages: 127
    Market Overview of Global Dihydroartemisinin market: According to our latest research, the global Dihydroartemisinin market looks promising in the next 5 years. As of 2022, the global Dihydroartemisinin market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Dihydroartemisini......
  • Global Artemisinin Market Insights, Forecast to 2029
    Published: 20-Sep-2023        Price: US 4900 Onwards        Pages: 108
    Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast. The global Artemisinin market is projected to grow from US$ 75 million in 2023 to US$ 225.3 million by 2029, at a Compound Annual Growth Rate......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs